Xvivo Perfusion AB (publ)

OM:XVIVO Stock Report

Market Cap: kr11.9b

Xvivo Perfusion Management

Management criteria checks 3/4

Xvivo Perfusion's CEO is Christoffer Rosenblad, appointed in Jan 2022, has a tenure of 2.33 years. directly owns 0.18% of the company’s shares, worth SEK21.08M. The average tenure of the management team and the board of directors is 3.5 years and 3.6 years respectively.

Key information

Christoffer Rosenblad

Chief executive officer

kr5.0m

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownership0.2%
Management average tenure3.5yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected

Apr 25
Xvivo Perfusion AB (publ) (STO:XVIVO) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected

There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital

Apr 11
There Are Reasons To Feel Uneasy About Xvivo Perfusion's (STO:XVIVO) Returns On Capital

Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates

Feb 05
Need To Know: Analysts Just Made A Substantial Cut To Their Xvivo Perfusion AB (publ) (STO:XVIVO) Estimates

We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings

Feb 01
We Think That There Are Issues Underlying Xvivo Perfusion's (STO:XVIVO) Earnings

Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jan 28
Earnings Beat: Xvivo Perfusion AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled

Aug 24
Returns On Capital At Xvivo Perfusion (STO:XVIVO) Have Stalled

Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching

Jul 17
Why Xvivo Perfusion AB (publ) (STO:XVIVO) Could Be Worth Watching

Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?

Jun 16
Do Xvivo Perfusion's (STO:XVIVO) Earnings Warrant Your Attention?

Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital

Apr 19
Xvivo Perfusion (STO:XVIVO) May Have Issues Allocating Its Capital

Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?

Mar 23
Are Investors Undervaluing Xvivo Perfusion AB (publ) (STO:XVIVO) By 21%?

With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case

Mar 07
With EPS Growth And More, Xvivo Perfusion (STO:XVIVO) Makes An Interesting Case

When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?

Feb 13
When Should You Buy Xvivo Perfusion AB (publ) (STO:XVIVO)?

Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

Dec 14
Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?

Nov 17
Is There An Opportunity With Xvivo Perfusion AB (publ)'s (STO:XVIVO) 35% Undervaluation?

Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively

Aug 20
Xvivo Perfusion (STO:XVIVO) Might Be Having Difficulty Using Its Capital Effectively

Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are

Jul 21
Statutory Profit Doesn't Reflect How Good Xvivo Perfusion's (STO:XVIVO) Earnings Are

Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

Mar 30
Be Wary Of Xvivo Perfusion (STO:XVIVO) And Its Returns On Capital

At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?

Feb 18
At kr258, Is Xvivo Perfusion AB (publ) (STO:XVIVO) Worth Looking At Closely?

A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Jan 30
A Look At The Fair Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Calculating The Intrinsic Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Apr 09
Calculating The Intrinsic Value Of Xvivo Perfusion AB (publ) (STO:XVIVO)

Should You Think About Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Now?

Mar 19
Should You Think About Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Now?

What Type Of Shareholders Own The Most Number of Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

Feb 26
What Type Of Shareholders Own The Most Number of Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

Have Insiders Been Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

Feb 05
Have Insiders Been Buying Xvivo Perfusion AB (publ) (STO:XVIVO) Shares?

CEO

Christoffer Rosenblad (48 yo)

2.3yrs

Tenure

kr5,031,000

Compensation

Mr. Christoffer Rosenblad serves as Chief Executive Officer at Xvivo Perfusion AB (publ) since November 30, 2022. He served as Deputy Chief Executive Officer and Global Business Development & Service Direc...

Leadership Team

NamePositionTenureCompensationOwnership
Christoffer Rosenblad
Chief Executive Officer2.3yrskr5.03m0.18%
SEK 21.1m
Kristoffer Nordstrom
CFO & Investor Relation3.5yrsno data0.0085%
SEK 1.0m
Lena Hagman
Chief Operating Officer1.4yrsno data0.0063%
SEK 758.1k
Ylva Vihoj
Global Human Resources Director1.3yrsno datano data
Magnus Nilsson
Senior Advisor3.9yrskr1.62mno data
Andreas Wallinder
Chief Medical Officer3.7yrsno data0.011%
SEK 1.3m
Johan Holmstrom
Chief Commercial Officer3.7yrsno data0.012%
SEK 1.4m

3.5yrs

Average Tenure

53yo

Average Age

Experienced Management: XVIVO's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gosta Johannesson
Chairman of the Board11.3yrskr440.00k0.015%
SEK 1.8m
Lars Henriksson
Independent Director3.6yrsno data0.0060%
SEK 719.9k
Erik Stromqvist
Independent Director1.1yrsno data0.18%
SEK 21.1m
Camilla Oberg
Independent Director8yrskr130.00k0.0034%
SEK 408.3k
Lena Hoglund
Independent Director3.6yrsno data0.0041%
SEK 493.1k
Goran Dellgren
Independent Director2.1yrsno datano data

3.6yrs

Average Tenure

62.5yo

Average Age

Experienced Board: XVIVO's board of directors are considered experienced (3.6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.